Avricore Health Inc. AVCR.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 71.16% | 32.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 71.16% | 32.92% | |||
| Cost of Revenue | 41.05% | 30.14% | |||
| Gross Profit | 116.13% | -19.23% | |||
| SG&A Expenses | 0.06% | -32.34% | |||
| Depreciation & Amortization | -- | 358.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.25% | -23.98% | |||
| Operating Income | 6.01% | 29.64% | |||
| Income Before Tax | -31.64% | 78.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.64% | 78.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.64% | 78.23% | |||
| EBIT | 6.01% | 29.64% | |||
| EBITDA | 3.22% | 27.70% | |||
| EPS Basic | -20.00% | 77.61% | |||
| Normalized Basic EPS | -33.33% | 40.00% | |||
| EPS Diluted | -20.00% | 77.61% | |||
| Normalized Diluted EPS | -33.33% | 40.00% | |||
| Average Basic Shares Outstanding | 3.54% | 0.00% | |||
| Average Diluted Shares Outstanding | 3.54% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||